Although the precise mechanisms of HSD17B13 variants in MASH remain unclear, studies have identified that protein kinase A-mediated phosphorylation of HSD17B13 interacts with adipose triglyceride lipase to promote lipolysis and suppress MASH 66
Regarding weight management, Wegovy and Saxenda may be the reason for some side effects, so its better to remember them and discuss them with a doctor if there are any concerns
This combined activity reduces food intake, improves insulin sensitivity, and increases metabolic rate
Glucagon receptor activity drives hepatic lipid mobilisation and a modest thermogenic component on top of the appetite and gastric-emptying effects driven by the incretin arms [3]
You arent just a number here
You can also typically use them twice daily without an adjustment period, unlike many other active ingredients